Ash Stevens provides current company and industry news to the media. If you are a member of the media and would like additional information, please contact Shelly Otenbaker, Eisbrenner Public Relations, at 248-641-1446 or sotenbaker@eisbrenner.com

4/21/08 - Ash Stevens Inc Named One of "Michigan's 50 Companies to Watch"

10/2/06 - Ash Stevens Awarded Two Contracts From The National Cancer Institute

1/3/05 - Ash Stevens Receives Third FDA Approval in 18 Months

5/21/04 - Ash Stevens to Manufacture New Cancer Drug

6/11/03 - Ash Stevens To Manufacture Promising New Cancer Drug

1/3/03 - Ash Stevens To Manufacture New Cancer Drug

12/10/02 - Ash Stevens Invests $12 Million in Facility Expansion, Pharmaceutical Technologies

7/18/01 - Ash Stevens Expands Riverview Facility Bringing Valuable Jobs to Community